feedback
facebook page
Follow Me on Pinterest
twitter page
google plus page
rss feed

Recalled Product

Item detail and remedy information

Search Recalls or Browse by Category
Consumer Products (?)
Food & Health (?)
Vehicles (?)
Home > Recalled Products > Drugs > Elevated Impurity > Losartan Potassium Hydrochlorothiazide Tablets

Recall: Losartan Potassium Hydrochlorothiazide Tablets

email
email

On 2018-11-08, the FDA announced that Sandoz is conducting a recall on Potassium Hydrochlorothiazide Tablets due to a possible ndea (n-nitrosodiethylamine). The recalled products were sold under the brand name(s) Losartan during an unspecified time period throughout the regions shown in the map below.

In recent months, there have been 5 drugs recalls due to potential elevated impurity, including irbesartan tablets, irbesartan tablets, usp 75 mg, 150 mg, and 300 mg dosage forms and more. Additionally, there have been 21 drug and medical device recalls due to other health hazards as well as 80 food recalls.

Email Me About Recalls On:
Food  |  Drugs  |  Medical Devices  |  Pet Care Products  |  All of These


Note: Images may not be available for every version. Please review the detailed description below.

Company Contact Information:

Name: Sandoz
Website: www.sandoz.com
Phone: 1-800-525-8747

Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.

Detailed Recall Information



Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.

Product Description: Potassium Hydrochlorothiazide Tablets

Brand Name(s): Losartan

Reason for Recall: NDEA (N-Nitrosodiethylamine) Impurity

Official Recall Date: 2018-11-08


Advertisement

Additional information provided by the FDA.gov:

Sandoz Inc. is voluntarily recalling one lot of Losartan Potassium Hydrochlorothiazide Tablets, USP 100mg/25mg to the consumer level. This product is being recalled due to the trace amount of an impurity, N-nitrosodiethylamine (NDEA) contained in the API Losartan, USP manufactured by Zhejiang Huahai Pharmaceutical Co. Ltd. Sandoz Inc. Losartan Potassium Hydrochlorothiazide product is manufactured by Lek Pharmaceuticals dd, Ljubljana, Slovenia. This impurity, which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC). Read More.


More information may be available at FDA.gov
Advertisement


Latest Safety Recalls

Select image for details, including additional styles.

 

Advertisement

Comments

Do you have comments or questions about this recall? Share them here.
Note: The recalling companies may not be monitoring these comments; they should be directed toward the public. Community Guidelines apply.
comments powered by Disqus
Back to Top



Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.

Search Recalled Products or Browse by Category
Consumer Products (?)
Food & Health (?)
Vehicles (?)
Latest Product Recalls
Consumers
Register Products
Check for Recalls
Find Resources
Brands & Retailers
Connect to Customers

Consignment Sales
Check Inventory
Install Recall Finder
Take Safety Pledge

Home Inspectors
Check Appliances
Developers
APIs & Feeds
Recall Search for Web
Recall Search for Mobile
Facebook Apps

Researchers
Product Recall Statistics
About
Company
Contact
Press
Blog

Social
Facebook
Twitter